These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23441663)

  • 1. Novel use of modafinal to treat severe physical and cognitive impairment post-stroke.
    Geffen S; Shum K; Tan HM
    Intern Med J; 2013 Mar; 43(3):338. PubMed ID: 23441663
    [No Abstract]   [Full Text] [Related]  

  • 2. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil for treatment of cognitive side effects of antiepileptic drugs in a patient with seizures and stroke.
    Smith BW
    Epilepsy Behav; 2003 Jun; 4(3):352-3. PubMed ID: 12791341
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of cognition and fatigue.
    Rubin SM
    Dis Mon; 2013 Jul; 59(7):269-72. PubMed ID: 23786661
    [No Abstract]   [Full Text] [Related]  

  • 5. [Noopept in the treatment of mild cognitive impairment in patients with stroke].
    Amelin AV; Iliukhina AIu; Shmonin AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):44-6. PubMed ID: 22500312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cellex on cognitive and speech impairments in the acute stage of stroke].
    Kovalenko AV; Safronova MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):40-44. PubMed ID: 25909788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive performance after lacunar stroke correlates with leukoaraiosis severity.
    McMurtray AM; Liao A; Haider J; Licht E; Mendez MF
    Cerebrovasc Dis; 2007; 24(2-3):271-6. PubMed ID: 17646691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke.
    Dong Y; Sharma VK; Chan BP; Venketasubramanian N; Teoh HL; Seet RC; Tanicala S; Chan YH; Chen C
    J Neurol Sci; 2010 Dec; 299(1-2):15-8. PubMed ID: 20889166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive disorders in stroke patients: the possibilities of pharmacological correction].
    Belskaya GN; Chuprina SE; Vorobyev AA; Gorozha EN; Butorakina TL; Sokolov MA; Izmaylov IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):33-37. PubMed ID: 27240178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NIH stroke scale can establish cognitive function after stroke.
    Cumming TB; Blomstrand C; Bernhardt J; Linden T
    Cerebrovasc Dis; 2010; 30(1):7-14. PubMed ID: 20424439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of memotropil for treatment of mild cognitive impairment in out-patients with progressive chronic cerebrovascular disorders].
    Batysheva TT; Bagir' LV; Kostenko EV; Artemova IIu; Bdovichenko TV; Gazhula PA; Zhuravleva EIu; Ismailov AM; Lisenker LN; Nesterova OV; Otcheskaia OV; Rotor LD; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):40-44. PubMed ID: 18689009
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on: "Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence".
    Whitlock DR
    CNS Drugs; 2014 Dec; 28(12):1205-6. PubMed ID: 25373628
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determinants and longitudinal course of post-stroke mild cognitive impairment.
    Sachdev PS; Chen X; Brodaty H; Thompson C; Altendorf A; Wen W
    J Int Neuropsychol Soc; 2009 Nov; 15(6):915-23. PubMed ID: 19891821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
    Ignatowski TA; Spengler RN; Tobinick E
    CNS Drugs; 2014 Dec; 28(12):1207-13. PubMed ID: 25373629
    [No Abstract]   [Full Text] [Related]  

  • 16. Cognitive dysfunction and physical activity after stroke: the Gothenburg cognitive stroke study in the elderly.
    Påhlman U; Sävborg M; Tarkowski E
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):652-8. PubMed ID: 21458296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of modafinil in stimulant abusers: low abuse potential.
    Malcolm R; Book SW; Moak D; DeVane L; Czepowicz V
    Am J Addict; 2002; 11(3):247-9. PubMed ID: 12202017
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing cognitive impairment following stroke.
    McDonnell MN; Bryan J; Smith AE; Esterman AJ
    J Clin Exp Neuropsychol; 2011 Nov; 33(9):945-53. PubMed ID: 21644141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
    de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM
    Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of domain-specific cognitive abilities in acute first-ever stroke.
    Nys GM; van Zandvoort MJ; de Kort PL; van der Worp HB; Jansen BP; Algra A; de Haan EH; Kappelle LJ
    Neurology; 2005 Mar; 64(5):821-7. PubMed ID: 15753416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.